Novacyt is a rapidly growing, international diagnostics group, generating revenues from the sale of diagnostic and pathogen testing kits based on molecular and protein testing technologies and sold into human clinical, life science, food and industrial markets.

Our Latest News

25 January 2022

Strategy and Full Year 2021 Trading Update and Interview with David Allmond


Omicron Variant Update: Novacyt Group Assay Performance

Our 2020 Annual Report